Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered l
ung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)

Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Sou...
Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered l
ung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)